Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moreno Di Marco

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Genome Medicine|April 2, 2020
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapyAnna Reustle, Moreno Di Marco, Carolin Meyerhoff, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|July 3, 2023
Prioritizing the reassessment of data-deficient species on the IUCN Red ListVictor Cazalis, Luca Santini, Pablo M Lucas, et al.
Science (New York, N.Y.)|June 2, 2022
The minimum land area requiring conservation attention to safeguard biodiversityJames R Allan, Hugh P Possingham, Scott C Atkinson, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|August 27, 2015
Quantifying the relative irreplaceability of important bird and biodiversity areasMoreno Di Marco, Thomas Brooks, Annabelle Cuttelod, et al.
Trends in Ecology & Evolution|January 23, 2022
Bridging the research-implementation gap in IUCN Red List assessmentsVictor Cazalis, Moreno Di Marco, Stuart H M Butchart, et al.
Nature|November 4, 2021
Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARsMark Yarmarkovich, Quinlen F Marshall, John M Warrington, et al.
Nature|November 8, 2023
Targeting of intracellular oncoproteins with peptide-centric CARsMark Yarmarkovich, Quinlen F Marshall, John M Warrington, et al.
Proceedings. Biological Sciences|June 30, 2026
Three decades of classifying threatened species: lessons learned from and about the IUCN Red List criteria for quantifying extinction riskH Resit Akçakaya, E J Milner-Gulland, Mike Hoffmann, et al.
Journal for Immunotherapy of Cancer|November 16, 2019
A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteerHans-Georg Rammensee, Karl-Heinz Wiesmüller, P Anoop Chandran, et al.
Plos One|August 17, 2016
Assessing the Cost of Global Biodiversity and Conservation KnowledgeDiego Juffe-Bignoli, Thomas M Brooks, Stuart H M Butchart, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Genome Medicine|April 2, 2020
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapyAnna Reustle, Moreno Di Marco, Carolin Meyerhoff, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|July 3, 2023
Prioritizing the reassessment of data-deficient species on the IUCN Red ListVictor Cazalis, Luca Santini, Pablo M Lucas, et al.
Science (New York, N.Y.)|June 2, 2022
The minimum land area requiring conservation attention to safeguard biodiversityJames R Allan, Hugh P Possingham, Scott C Atkinson, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|August 27, 2015
Quantifying the relative irreplaceability of important bird and biodiversity areasMoreno Di Marco, Thomas Brooks, Annabelle Cuttelod, et al.
Trends in Ecology & Evolution|January 23, 2022
Bridging the research-implementation gap in IUCN Red List assessmentsVictor Cazalis, Moreno Di Marco, Stuart H M Butchart, et al.
Nature|November 4, 2021
Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARsMark Yarmarkovich, Quinlen F Marshall, John M Warrington, et al.
Nature|November 8, 2023
Targeting of intracellular oncoproteins with peptide-centric CARsMark Yarmarkovich, Quinlen F Marshall, John M Warrington, et al.
Proceedings. Biological Sciences|June 30, 2026
Three decades of classifying threatened species: lessons learned from and about the IUCN Red List criteria for quantifying extinction riskH Resit Akçakaya, E J Milner-Gulland, Mike Hoffmann, et al.
Journal for Immunotherapy of Cancer|November 16, 2019
A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteerHans-Georg Rammensee, Karl-Heinz Wiesmüller, P Anoop Chandran, et al.
Plos One|August 17, 2016
Assessing the Cost of Global Biodiversity and Conservation KnowledgeDiego Juffe-Bignoli, Thomas M Brooks, Stuart H M Butchart, et al.
Pageof 8